| CYSB2500261 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2025-10-01 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2500260 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2025-10-01 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2500226 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.3) | Supplementary Application | 2025-09-16 | | Shanghai Institute of Biological Products Co Ltd | | | view |
| JYSZ2500028 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2025-09-12 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JYSZ2500029 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2025-09-12 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JYSZ2500026 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2025-09-12 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JYSZ2500027 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2025-09-12 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| CYSB2500117 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2025-05-24 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2500075 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2025-04-03 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| CYSB2500076 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2025-04-03 | | Shanghai Fuhong Ruilin Biotechnology Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JXSS2500031 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS2500032 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS2500035 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS2500033 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS2500036 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS2500029 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS2500034 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSS2500030 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(2.2) | Import Drug Application | 2025-03-22 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| CXSS2400128 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.3) | New Drug Application | 2024-11-23 | | Hualan Genetic Engineering Co Ltd | | | view |
| CXSS2400127 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.3) | New Drug Application | 2024-11-23 | | Hualan Genetic Engineering Co Ltd | | | view |
